Evaluation of a Novel Slow-Release Paclitaxel-Eluting Stent With a Bioabsorbable Polymeric Surface Coating

JACC: Cardiovascular Interventions

Volumn 1, Issue 1, 2008, Pages 81-87

  Jabara, Refat ^a   Chronos, Nicolas ^a   Conway, Damian ^b   Molema, Warner ^b   Robinson, Keith ^a  

^a Saint Joseph's Hospital of Atlanta   (United States)

^b DISA Vascular Ltd   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHROMIUM; CLOPIDOGREL; COBALT; HEPARIN; METAL; PACLITAXEL; POLYGLACTIN; POLYMER;

ACUTE TOXICITY; ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOLOGICAL ACTIVITY; BLEEDING; BLOOD VESSEL COMPLIANCE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFICACY; DRUG ELUTING STENT; ELUTION; HEART CATHETERIZATION; HEPARINIZATION; HISTOPATHOLOGY; IN VITRO STUDY; LOW DRUG DOSE; MATERIAL COATING; MORPHOMETRICS; NONHUMAN; PREOPERATIVE CARE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STENOSIS; VASCULAR NECROSIS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; COATED MATERIALS, BIOCOMPATIBLE; CORONARY DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG-ELUTING STENTS; LACTIC ACID; PACLITAXEL; POLYGLYCOLIC ACID; PROSTHESIS DESIGN; SWINE;

EID: 41249100615     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2007.11.009     Document Type: Article

References (17)

1. Jabara R., Chronos N., Tondato F., et al. Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries. J Invasive Cardiol 18 (2006) 383-390
2. Heldman A.W., Cheng L., Jenkins G.M., et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 103 (2001) 2289-2295
3. Rogers C.D. Drug-eluting stents: clinical perspectives on drug and design differences. Rev Cardiovasc Med 6 Suppl 1 (2005) S3-S12
4. Virmani R., Guagliumi G., Farb A., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious. Circulation 109 (2004) 701-705
5. Virmani R., Farb A., Guagliumi G., and Kolodgie F.D. Drug-eluting stents: caution and concerns for long term outcome. Coron Artery Dis 15 (2004) 313-318
6. Farb A., Heller P.F., Shroff S., et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104 (2001) 473-479
7. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
8. Camenzind E., Steg P.G., and Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115 (2007) 1440-1455
9. Finn A.V., Nakazawa G., Joner M., et al. Vascular responses to drug eluting stents. Importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
10. Schwartz R.S., Edelman E.R., Carter A., et al. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation 106 (2002) 1867-1873
11. Baek N., Lee J., and Park K. Aqueous N,N-diethylnicotinamide solution as a medium for accelerated release study of paclitaxel. J Biomater Sci Polymer Edn 15 (2004) 527-542
12. Kornowski R., Hong M.K., Tio F.O., Bramwell O., Wu H., and Leon M.B. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31 (1998) 224-230
13. Schwartz R.S., Huber K.C., Murphy J.G., et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 19 (1992) 267-274
14. Serruys P.W., Degertekin M., Tanabe K., et al., RAVEL Study Group. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 106 (2002) 798-803
15. Tanabe K., Serruys P.W., Degertekin M., et al., TAXUS II Study Group. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial. Circulation 109 (2004) 196-200
16. Cook S., Wenaweser P., Togni M., et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115 (2007) 2426-2434
17. Virmani R., Kolodgie F.D., Farb A., and Lafant A. Drug eluting stents: are human and animal studies comparable?. Heart 89 (2003) 133-138